Big Gain For Karyopharm Therapeutics Inc.
Wed, Nov 03, 2021 at 05:30 PM
Karyopharm Therapeutics Inc. (KPTI:NASDAQ) jumped higher at $7.94, a gain of 37.4%. On Tue, Nov 02, 2021, KPTI:NASDAQ touched a New 2-Week Intraday High of $5.87. The stock appeared on our News Catalysts scanner on Wed, Nov 03, 2021 at 08:46 AM in the 'EARNINGS' category. From Tue, Oct 19, 2021, the stock recorded 30.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Karyopharm Therapeutics Inc. (KPTI:NASDAQ)
Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class drugs directed against nuclear transport and related targets to treat cancer and other diseases.
Top 10 Gainers:
- PTPI (PTPI:NASDAQ), 64.57%
- iRhythm Technologies, Inc. (IRTC:NASDAQ), 59.01%
- XRTX (XRTX:NASDAQ), 41.76%
- R. R. Donnelley & Sons Company (RRD:NYSE), 38.03%
- Karyopharm Therapeutics Inc. (KPTI:NASDAQ), 37.37%
- TDH Holdings, Inc. (PETZ:NASDAQ), 33.9%
- BlueLinx Holdings Inc. (BXC:NYSE), 31.46%
- Veritiv Corporation (VRTV:NYSE), 29.71%
- OG (OG:NYSE), 26.4%
- Criteo S.A. (CRTO:NASDAQ), 24.77%